Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

INTRODUCTION: Degludec (IDeg) is an ultralong-acting insulin, with stable pharmacodynamic profile which leads to lower fluctuations in glucose levels. The effect of IDeg has not been specifically assessed in patients with unstable diabetes, defined as increased glycemic variability (GV). METHODS: A...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Transl Endocrinol
Glavni autori: Henao-Carrillo, Diana Cristina, Muñoz, Oscar M., Gómez, Ana M., Rondón, Martín, Colón, Christian, Chica, L., Rubio, Claudia, León-Vargas, Fabián, Calvachi, Maria Alejandra, Perea, Ana María
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992319/
https://ncbi.nlm.nih.gov/pubmed/29892561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcte.2018.03.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items